SLC25A51 is a mammalian mitochondrial NAD+ transporter

Timothy S. Luongo,Jared M. Eller,Mu-Jie Lu,Marc Niere,Fabio Raith,Caroline Perry,Marc R. Bornstein,Paul Oliphint,Lin Wang,Melanie R. McReynolds,Marie E. Migaud,Joshua D. Rabinowitz,F. Brad Johnson,Kai Johnsson,Mathias Ziegler,Xiaolu A. Cambronne,Joseph A. Baur
DOI: https://doi.org/10.1038/s41586-020-2741-7
IF: 64.8
2020-09-09
Nature
Abstract:Mitochondria require nicotinamide adenine dinucleotide (NAD<sup>+</sup>) in order to carry out the fundamental processes that fuel respiration and mediate cellular energy transduction. Mitochondrial NAD<sup>+</sup> transporters have been identified in yeast and plants<sup>1,2</sup> but their very existence is controversial in mammals<sup>3–5</sup>. Here we demonstrate that mammalian mitochondria are capable of taking up intact NAD<sup>+</sup> and identify SLC25A51 (an essential<sup>6,7</sup> mitochondrial protein of previously unknown function, also known as MCART1) as a mammalian mitochondrial NAD<sup>+</sup> transporter. Loss of SLC25A51 decreases mitochondrial but not whole-cell NAD<sup>+</sup> content, impairs mitochondrial respiration, and blocks the uptake of NAD<sup>+</sup> into isolated mitochondria. Conversely, overexpression of SLC25A51 or a nearly identical paralog, SLC25A52, increases mitochondrial NAD<sup>+</sup> levels and restores NAD<sup>+</sup> uptake into yeast mitochondria lacking endogenous NAD<sup>+</sup> transporters. Together, these findings identify SLC25A51 as the first transporter capable of importing NAD<sup>+</sup> into mammalian mitochondria.
multidisciplinary sciences
What problem does this paper attempt to address?